Modulation of Th1/Th2 cytokines and inflammatory mediators by hydroxychavicol in adjuvant induced arthritic tissues

Cytokine

Volumn 49, Issue 1, 2010, Pages 114-121

  Pandey, Anjali ^a   Bani, Sarang ^a   Dutt, Prabhu ^a   Suri, Krishna Avtar ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Arthritis; Cytometric bead array; Flowcytometry; Hydroxychavicol; Piper betle

Indexed keywords

ANTIRHEUMATIC AGENT; CYTOKINE; GAMMA INTERFERON; HYDROXYCHAVICOL; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE B4; NITRIC OXIDE; PREDNISOLONE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; IMMUNOASSAY; IMMUNOMODULATION; MOUSE; NONHUMAN; PIPER BETLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SPLEEN CELL; SUPERNATANT; TH1 CELL; TH2 CELL; TISSUE HOMOGENATE;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; EUGENOL; FEMALE; IMMUNOASSAY; INFLAMMATION MEDIATORS; MAXIMUM TOLERATED DOSE; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; PIPER BETLE; PLANT EXTRACTS; SPLEEN; TH1 CELLS; TH2 CELLS;

ANIMALIA; MUS; PIPER BETLE; PIPERACEAE; RATTUS;

EID: 71649105602     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.08.015     Document Type: Article

References (34)

1. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 (1986) 2348-2357
2. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
3. Miossec P., and van der Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 40 (1997) 2105-2115
4. Kamradt T., and Burmester G.R. Cytokines and arthritis: is the Th1/Th2 paradigm useful for understanding pathogenesis?. J Rheumatol 25 (1998) 6-7
5. Shapiro H. Practical flowcytometry. 3rd ed. (1994), Wiley-Liss, New York
6. Feldmann M., and Maini R.N. Anti-TNFα therapy of rheumatoid arthritis: what have we learned?. Annu Rev Immunol 19 (2001) 163-196
7. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 (1996) 397-440
8. Panayi G.S., Lanchbury J.S., and Kingsley G.H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35 (1992) 729-735
9. Rosloniec E.F., Latham K., and Guedez Y.B. Paradoxical roles of IFN-γ in models of Th1-mediated autoimmunity. Arthritis Res 4 (2002) 333-336
10. Evans C.H., and Evans M. Nitric oxide in arthritis. Methods 10 (1996) 38-42 Article No. 0076
11. Chang M.C., Uang B.J., Wu H.L., Lee J.J., Hahn L.J., and Jeng J.H. A major phenolic compound in Piper betle leaves. Br J Pharmacol 133 (2002) 619-630
12. Jeng J.H., Wang Y.J., and Chang W.H. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell Mol Life Sci 61 (2004) 83-96
13. Sharma S., Khan I.A., Ali I., Ali F., Kumar M., Kumar A., et al. Evaluation of the antimicrobial, anti-oxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother 52 (2008) 9
14. Organization for Economic Cooperation and Development. OECD guidelines for testing of chemicals. Guideline 423, acute oral toxicity - acute toxic class method, adopted, March 22, 1996.
15. Newbould B.B. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol 21 (1963) 127-136
16. Arrigoni-Martelli E., and Brahm E. Investigations in the influence of cyclophosphamide gold sodium thiomalate and d-penicillamine on nystatin oedema and adjuvant arthritis. Agents Actions 5 (1975) 264-267
17. Arrigoni-Martelli E., Brahm E., Huskisson E.C., Willoghby D.A., and Dieppe P.A. An experimental model for the action of penicillamine-like drugs. Agents Actions 6 (1976) 613-617
18. Magari K., Miyata S., Ohkubo Y., and Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Inflamm Res 53 (2004) 469-474
19. Chen R., Lowe L., Wilson J.D., Crowther E., Tzeggai K., Bishop J.E., et al. Simultaneous quantification of six human cytokines in a single sample using microparticle based flow cytometric technology. Clin Chem 45 9 (1999) 1693
20. Wang Y.P., and Li X.Y. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 3 (2002) 263-266
21. Khajuria A., Gupta A., Malik F., Singh S., Singh J., Gupta B.D., et al. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 25 23 (2007) 4586-4594
22. Panayi G.S. T cell-dependent pathways in rheumatoid arthritis. Cur Opin Rheumatol 9 (1977) 236-240
23. Garra O. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 (1998) 275-283
24. Lissoni P., Malugani F., and Malysheva O. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose, interleukin-2, melatonin and naltrexone, modulation of interleukin-2-induced antitumor immunity by blocking the opoid system. Neuroendocrinol Lett 23 (2002) 341-344
25. Tabata N., Tagami H., and Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 289 (1997) 410-414
26. Billingham M.E.J., and Davies G.E. Experimental models of arthritis in animals as screening tests for drugs to treat arthritis in man. Handb Exp Pharmacol 50 2 (1979) 108-144
27. Dean J.H., Padarathsingh M.L., and Jarrels J.R. Application of immunocompetence assays for defining immunosuppression. Ann NY Acad Sci 320 (1979) 579
28. Luster M.I., Dean J.H., and Boorman G.A. A cell mediated immunity and its application in toxicology. Environ Health Perspect 43 (1982) 31-36
29. Luster M.I., Dean J.H., and Moore J.A. Evaluation of immune functions in toxicology. In: Hayes W. (Ed). Methods in toxicology (1982), Raven Press, New York 561-586
30. Sebbag M., Parry S.L., Brennan F.M., and Feldmann M. Cytokine stimulation of T-lymphocytes regulates their capacity to induce monocyte production of tumour necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol 27 (1997) 624-632
31. Numerof R.P., Aronson F.R., and Mier J.W. IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells. J Immunol 141 (1988) 4250-4257
32. Ronit H., Dan A., Abraham S., Alan N., Redwan M., and Francesca L.S. Interleukin-2 activates human peripheral blood eosinophils. Cell Immunol 21 2 (2001) 116-124
33. Waksman B.H., Pearson C.M., and Sharp J.T. Studies of arthritis and another lesions induced in rats by injection of mycobacterial adjuvant-II: evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol 85 (1960) 403-417
34. Singh S., Bani S., Singh G.B., Gupta B.D., Banerjee S.K., and Singh B. Evaluation of Lupeol for anti-inflammatory activity. Fitoterapia LX VIII 1 (1997) 9-16